{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"columns":[{"gene":"","key":"MONDO:0013779/OMIM:614493","label":"Wiskott-Aldrich syndrome 2","mondoId":"MONDO:0013779","onsetQualifier":null,"recordKeys":["077c68a2fe931fd26bedd99984164335a4b70fb612c4295cedde1c5e0dcff1f5","1b0ae142493bf6b2f72e5b648ade0b0f489e218978527ed01dd65b16b5635806","3b6ea0d3ce5d09e8e7ea86ec7d97878032f71f5d6b941b7c0f7735c9f9b818cb","9b4109f4f443dde9c0c2aa26409a6a70c31b3eecfe657edffc0f5851fc2fc337","e22a7b2be138ab3e9dbc4c4ffaf5dc95861d8abcf574f0ba7ff722eaa7307da6","f8654bcf5022a73fedd7b623a79b1948f14adbe6d19b1a8c1d3a81b6a270d902"],"recordQualifiers":{},"scopeLabel":"OMIM:614493","sourceIds":["OMIM:614493"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show initial comparisons","defaultColumnKeys":["MONDO:0013779/OMIM:614493"],"expandColumnsLabel":"Compare all source entries","intro":"Compare the original source entries. Different entries may describe different patient groups.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column keeps its native condition scope. Initial features are displayed alphabetically, not ranked by clinical importance. Counts remain separate, and an empty cell does not mean a feature cannot occur.</p>"},"coverage":{"countRecords":6,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":6,"sourceGroups":{"omim":0,"orphanet":0,"published":6}},"features":[{"hpoId":"HP:0012177","label":"Abnormal natural killer cell physiology","primary":false},{"hpoId":"HP:0031379","label":"Abnormal T cell proliferation","primary":false},{"hpoId":"HP:0005415","label":"Decreased total CD8+ T cell proportion","primary":false},{"hpoId":"HP:0000964","label":"Eczematoid dermatitis","primary":false},{"hpoId":"HP:0002719","label":"Recurrent infections","primary":false},{"hpoId":"HP:0001873","label":"Thrombocytopenia","primary":false}],"ledeHtml":"A patient-friendly description is not yet available in the ingested narrative sources for this condition.","mondoId":"MONDO:0013779","records":[{"frequencyKind":"count","key":"077c68a2fe931fd26bedd99984164335a4b70fb612c4295cedde1c5e0dcff1f5","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:614493","disease_name":"Wiskott-Aldrich syndrome 2","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0031379","is_excluded":false,"label":"Abnormal T cell proliferation","onset_id":null,"reference":"PMID:22231303","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"1b0ae142493bf6b2f72e5b648ade0b0f489e218978527ed01dd65b16b5635806","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:614493","disease_name":"Wiskott-Aldrich syndrome 2","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0002719","is_excluded":false,"label":"Recurrent infections","onset_id":null,"reference":"PMID:22231303","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"3b6ea0d3ce5d09e8e7ea86ec7d97878032f71f5d6b941b7c0f7735c9f9b818cb","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:614493","disease_name":"Wiskott-Aldrich syndrome 2","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0000964","is_excluded":false,"label":"Eczematoid dermatitis","onset_id":null,"reference":"PMID:22231303","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"9b4109f4f443dde9c0c2aa26409a6a70c31b3eecfe657edffc0f5851fc2fc337","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:614493","disease_name":"Wiskott-Aldrich syndrome 2","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0005415","is_excluded":false,"label":"Decreased total CD8+ T cell proportion","onset_id":null,"reference":"PMID:22231303","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"e22a7b2be138ab3e9dbc4c4ffaf5dc95861d8abcf574f0ba7ff722eaa7307da6","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:614493","disease_name":"Wiskott-Aldrich syndrome 2","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0001873","is_excluded":false,"label":"Thrombocytopenia","onset_id":null,"reference":"PMID:22231303","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"f8654bcf5022a73fedd7b623a79b1948f14adbe6d19b1a8c1d3a81b6a270d902","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:614493","disease_name":"Wiskott-Aldrich syndrome 2","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0012177","is_excluded":false,"label":"Abnormal natural killer cell physiology","onset_id":null,"reference":"PMID:22231303","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p>No mapped MedlinePlus condition document in this snapshot.</p>","identityNote":"MONDO defines condition identity and route membership. Native evidence populations and narrative coverage retain their separate scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>No MedlinePlus narrative has been mapped to this MONDO condition. Feature annotations, when available, are retained below.</p>","key":"overview","title":"Condition overview"}],"sharedSources":[],"slug":"wiskott-aldrich-syndrome-2","sourceDocuments":[],"sourceNote":"MONDO condition identity; scoped MedlinePlus enrichment where available; original HPO annotations.","takeawayHtml":"Cause information is not available in the mapped narrative sources for this condition.","title":"Wiskott-Aldrich syndrome 2"},"schemaVersion":1}